Acute 0 5 0 5 B-chronic_disease
or 6 8 6 8 I-chronic_disease
chronic 9 16 9 16 I-chronic_disease
severe 17 23 17 23 I-chronic_disease
renal 24 29 24 29 I-chronic_disease
insufficiency 30 43 30 43 I-chronic_disease

Acute 0 5 44 49 B-chronic_disease
renal 6 11 50 55 I-chronic_disease
dysfunction 12 23 56 67 I-chronic_disease
due 24 27 68 71 O
to 28 30 72 74 O
the 31 34 75 78 O
hepato 35 41 79 85 B-chronic_disease
- 41 42 85 86 I-chronic_disease
renal 42 47 86 91 I-chronic_disease
syndrome 48 56 92 100 I-chronic_disease
or 57 59 101 103 O
in 60 62 104 106 O
the 63 66 107 110 O
perioperative 67 80 111 124 B-treatment
liver 81 86 125 130 I-treatment
transplantation 87 102 131 146 I-treatment
period 103 109 147 153 O

Age 0 3 154 157 B-age
> 4 5 158 159 O
60 6 8 160 162 B-lower_bound

Exposure 0 8 163 171 B-chronic_disease
to 9 11 172 174 I-chronic_disease
gadolinium 12 22 175 185 I-chronic_disease
- 22 23 185 186 I-chronic_disease
based 23 28 186 191 I-chronic_disease
contrast 29 37 192 200 I-chronic_disease
agents 38 44 201 207 I-chronic_disease
increases 45 54 208 217 I-chronic_disease
the 55 58 218 221 I-chronic_disease
risk 59 63 222 226 I-chronic_disease
for 64 67 227 230 I-chronic_disease
nephrogenic 68 79 231 242 I-chronic_disease
systemic 80 88 243 251 I-chronic_disease
fibrosis 89 97 252 260 I-chronic_disease
( 98 99 261 262 I-chronic_disease
NSF 99 102 262 265 I-chronic_disease
) 102 103 265 266 I-chronic_disease
in 104 106 267 269 I-chronic_disease
patients 107 115 270 278 I-chronic_disease
with 116 120 279 283 I-chronic_disease
acute 121 126 284 289 I-chronic_disease
or 127 129 290 292 I-chronic_disease
severe 130 136 293 299 I-chronic_disease
renal 137 142 300 305 I-chronic_disease
dysfunction 143 154 306 317 I-chronic_disease

History 0 7 318 325 O
of 8 10 326 328 O
diabetes 11 19 329 337 B-chronic_disease

History 0 7 338 345 O
of 8 10 346 348 O
hypertension 11 23 349 361 B-chronic_disease

History 0 7 362 369 O
of 8 10 370 372 O
severe 11 17 373 379 O
hepatic 18 25 380 387 B-chronic_disease
disease 26 33 388 395 I-chronic_disease
/ 33 34 395 396 O
liver 34 39 396 401 B-treatment
transplant 40 50 402 412 I-treatment
/ 50 51 412 413 O
pending 51 58 413 420 O
liver 59 64 421 426 O
transplant 65 75 427 437 O

In 0 2 438 440 O
order 3 8 441 446 O
to 9 11 447 449 O
identify 12 20 450 458 O
subjects 21 29 459 467 O
at 30 32 468 470 O
risk 33 37 471 475 O
for 38 41 476 479 O
the 42 45 480 483 O
development 46 57 484 495 O
of 58 60 496 498 O
NSF 61 64 499 502 O
, 64 65 502 503 O
the 66 69 504 507 O
American 70 78 508 516 O
College 79 86 517 524 O
of 87 89 525 527 O
Radiology 90 99 528 537 O
( 100 101 538 539 O
http://acr.org 101 115 539 553 O
) 115 116 553 554 O
recommends 117 127 555 565 O
obtaining 128 137 566 575 O
a 138 139 576 577 O
medical 140 147 578 585 O
history 148 155 586 593 O
and 156 159 594 597 O
a 160 161 598 599 O
glomerular 162 172 600 610 B-clinical_variable
filtration 173 183 611 621 I-clinical_variable
rate 184 188 622 626 I-clinical_variable
( 189 190 627 628 I-clinical_variable
GFR 190 193 628 631 I-clinical_variable
) 193 194 631 632 I-clinical_variable
assessment 195 205 633 643 O
within 206 212 644 650 O
six 213 216 651 654 B-upper_bound
weeks 217 222 655 660 I-upper_bound
of 223 225 661 663 O
MR 226 228 664 666 O

Patients 0 8 667 675 O
can 9 12 676 679 B-pregnancy
not 12 15 679 682 I-pregnancy
be 16 18 683 685 I-pregnancy
pregnant 19 27 686 694 I-pregnancy
and 28 31 695 698 O
prisoners 32 41 699 708 O
will 42 46 709 713 O
not 47 50 714 717 O
be 51 53 718 720 O
considered 54 64 721 731 O
for 65 68 732 735 O
the 69 72 736 739 O
study 73 78 740 745 O

Patients 0 8 746 754 O
with 9 13 755 759 O
a 14 15 760 761 O
lesion 16 22 762 768 B-clinical_variable
< 23 24 769 770 O
2 25 26 771 772 B-upper_bound
mm 27 29 773 775 I-upper_bound

Renal 0 5 776 781 B-chronic_disease
disease 6 13 782 789 I-chronic_disease
( 14 15 790 791 O
including 15 24 791 800 O
solitary 25 33 801 809 B-chronic_disease
kidney 34 40 810 816 I-chronic_disease
, 40 41 816 817 O
renal 42 47 818 823 B-treatment
transplant 48 58 824 834 I-treatment
, 58 59 834 835 O
renal 60 65 836 841 B-cancer
tumor 66 71 842 847 I-cancer
) 71 72 847 848 O

The 0 3 849 852 O
patient 4 11 853 860 O
has 12 15 861 864 O
an 16 18 865 867 O
orbital 19 26 868 875 B-cancer
mass 27 31 876 880 I-cancer
which 32 37 881 886 O
needs 38 43 887 892 O
further 44 51 893 900 O
diagnostic 52 62 901 911 O
evaluation 63 73 912 922 O
before 74 80 923 929 O
treatment 81 90 930 939 B-treatment
or 91 93 940 942 O
for 94 97 943 946 O
monitoring 98 108 947 957 O

The 0 3 958 961 O
patient 4 11 962 969 O
should 12 18 970 976 O
not 19 22 977 980 O
participate 23 34 981 992 O
in 35 37 993 995 O
this 38 42 996 1000 O
study 43 48 1001 1006 O
is 49 51 1007 1009 O
any 52 55 1010 1013 O
of 56 58 1014 1016 O
the 59 62 1017 1020 O
following 63 72 1021 1030 O
applies 73 80 1031 1038 O
to 81 83 1039 1041 O
the 84 87 1042 1045 O
patient 88 95 1046 1053 O
: 95 96 1053 1054 O
the 97 100 1055 1058 O
patients 101 109 1059 1067 O
has 110 113 1068 1071 O
a 114 115 1072 1073 O
pacemaker 116 125 1074 1083 B-treatment
, 125 126 1083 1084 O
metallic 127 135 1085 1093 B-treatment
cardiac 136 143 1094 1101 I-treatment
valve(s 144 151 1102 1109 I-treatment
) 151 152 1109 1110 O
, 152 153 1110 1111 O
magnetic 154 162 1112 1120 O
material 163 171 1121 1129 O
such 172 176 1130 1134 O
as 177 179 1135 1137 O
surgical 180 188 1138 1146 O
clips 189 194 1147 1152 O
, 194 195 1152 1153 O
implanted 196 205 1154 1163 O
electronic 206 216 1164 1174 O
infusion 217 225 1175 1183 O
pumps 226 231 1184 1189 O
or 232 234 1190 1192 O
any 235 238 1193 1196 O
other 239 244 1197 1202 O
condition 245 254 1203 1212 O
that 255 259 1213 1217 O
would 260 265 1218 1223 O
interfere 266 275 1224 1233 O
with 276 280 1234 1238 O
the 281 284 1239 1242 O
MRI 285 288 1243 1246 B-treatment
, 288 289 1246 1247 O
the 290 293 1248 1251 O
patient 294 301 1252 1259 O
has 302 305 1260 1263 O
a 306 307 1264 1265 O
stent 308 313 1266 1271 O
somewhere 314 323 1272 1281 O
in 324 326 1282 1284 O
the 327 330 1285 1288 O
body 331 335 1289 1293 O
, 335 336 1293 1294 O
the 337 340 1295 1298 O
patient 341 348 1299 1306 O
has 349 352 1307 1310 O
a 353 354 1311 1312 O
history 355 362 1313 1320 O
of 363 365 1321 1323 O
allergic 366 374 1324 1332 O
reaction 375 383 1333 1341 O
to 384 386 1342 1344 O
any 387 390 1345 1348 O
metals 391 397 1349 1355 B-allergy_name
, 397 398 1355 1356 O
contrast 399 407 1357 1365 B-allergy_name
agents 408 414 1366 1372 I-allergy_name
, 414 415 1372 1373 O
x 416 417 1374 1375 B-allergy_name
- 417 418 1375 1376 I-allergy_name
ray 418 421 1376 1379 I-allergy_name
dyes 422 426 1380 1384 I-allergy_name
, 426 427 1384 1385 O
the 428 431 1386 1389 O
patient 432 439 1390 1397 O
has 440 443 1398 1401 O
claustrophobia 444 458 1402 1416 B-chronic_disease

glomerular 0 10 1417 1427 B-clinical_variable
filtration 11 21 1428 1438 I-clinical_variable
rate 22 26 1439 1443 I-clinical_variable
< 27 28 1444 1445 O
30 29 31 1446 1448 B-upper_bound
mL 32 34 1449 1451 I-upper_bound
/ 34 35 1451 1452 I-upper_bound
min/1.73 35 43 1452 1460 I-upper_bound
m^2 44 47 1461 1464 I-upper_bound

subjects 0 8 1465 1473 O
with 9 13 1474 1478 O
an 14 16 1479 1481 O
eGFR 17 21 1482 1486 B-clinical_variable
of 22 24 1487 1489 O
< 25 26 1490 1491 O
30 27 29 1492 1494 B-upper_bound
mL 30 32 1495 1497 I-upper_bound
/ 32 33 1497 1498 I-upper_bound
min/1.73 33 41 1498 1506 I-upper_bound
m^2 42 45 1507 1510 I-upper_bound

the 0 3 1511 1514 O
form 4 8 1515 1519 O
will 9 13 1520 1524 O
be 14 16 1525 1527 O
reviewed 17 25 1528 1536 O
to 26 28 1537 1539 O
determine 29 38 1540 1549 O
whether 39 46 1550 1557 O
the 47 50 1558 1561 O
subject 51 58 1562 1569 O
is 59 61 1570 1572 O
at 62 64 1573 1575 O
risk 65 69 1576 1580 O
as 70 72 1581 1583 O
defined 73 80 1584 1591 O
above 81 86 1592 1597 O
and 87 90 1598 1601 O
the 91 94 1602 1605 O
availability 95 107 1606 1618 O
of 108 110 1619 1621 O
an 111 113 1622 1624 O
estimated 114 123 1625 1634 B-clinical_variable
glomerular 124 134 1635 1645 I-clinical_variable
filtration 135 145 1646 1656 I-clinical_variable
rate 146 150 1657 1661 I-clinical_variable
( 151 152 1662 1663 I-clinical_variable
eGFR 152 156 1663 1667 I-clinical_variable
) 156 157 1667 1668 I-clinical_variable
within 158 164 1669 1675 O
six 165 168 1676 1679 B-upper_bound
weeks 169 174 1680 1685 I-upper_bound
of 175 177 1686 1688 O
anticipated 178 189 1689 1700 O
MR 190 192 1701 1703 O
imaging 193 200 1704 1711 O

